POMPANO BEACH, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading medtech company specializing in the development, manufacture, and commercialization of placental-derived allografts for advanced wound care, announced today that it will release its second quarter 2024 financial results after the market close on Monday,… Read More..

CHICAGO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Vocodia Holdings Corp. (CBOE: VHAI), a pioneering AI software company specializing in practical AI solutions, today invites the public to try out one of four groundbreaking Conversational AI demos to see how Vocodia’s Digital Intelligent Sales Agents (DISA) actually work. Vocodia’s technology platform harnessed… Read More..

ROCKVILLE, Md. & NEW YORK--(BUSINESS WIRE)-- OS Therapies Incorporated (“OS Therapies” or the “Company”) (NYSE-A: OSTX), a Cancer Immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced the formation of a Patient Advocacy Advisory Board (PAAB) for its osteosarcoma program. The purpose of the PAAB is to represent voices… Read More..